id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-N-0225-0006,FDA,FDA-1995-N-0225,"Reference 4 - Physicians' Desk Reference, 48th ed., Medical Economics Co., Montvale, NJ, p. 738, 1994.",Supporting & Related Material,Background Material,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T17:54:44Z,,0,0,09000064824a4be9
FDA-1995-N-0225-0005,FDA,FDA-1995-N-0225,"Reference 3 - Letter dated October 7, 1992, from R. W. Soller, Nonprescription Drug Manufacturers Association, to W. E. Gilbertson, FDA, in OTC Vol. 190036, Docket No. 95N 0062, Dockets Management Branch.",Supporting & Related Material,Background Material,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T15:19:08Z,,0,0,09000064824a4be8
FDA-1995-N-0225-0001,FDA,FDA-1995-N-0225,Topical Antimicrobial Drug Products For Over-The-Counter Human Use; Proposed Amendment of Final Monograph for OTC First Aid Antibiotic Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2017-02-01T05:00:00Z,2017,2,1996-02-14T05:00:00Z,1996-05-15T03:59:59Z,2024-07-30T14:48:31Z,96–3325,0,0,09000064805718b0
FDA-1995-N-0225-0010,FDA,FDA-1995-N-0225,Topical Antimicrobial Drug Products for Over–the–Counter Human Use; Amendment of Final Monograph for OTC First Aid Antibiotic Drug Products,Rule,Final Rule,2017-02-01T05:00:00Z,2017,2,,,2024-07-02T14:14:09Z,96-29302,0,0,09000064805718b9
FDA-1995-N-0225-0004,FDA,FDA-1995-N-0225,"Reference 2 - Letter dated July 22, 1992, from W. E. Gilbertson, FDA, to R. W. Soller, Nonprescription Drug Manufacturers Association, in OTC Vol. 190036, Docket No. 95N 0062, Dockets Management Branch.",Supporting & Related Material,Background Material,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T15:18:37Z,,0,0,09000064824a4be7
FDA-1995-N-0225-0007,FDA,FDA-1995-N-0225,Reference 1.2 - Memorandum of a Meeting between NMC Labs and FDA CDER,Supporting & Related Material,Background Material,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T17:59:08Z,,0,0,09000064824a4bea
FDA-1995-N-0225-0003,FDA,FDA-1995-N-0225,"Reference 1 - Letter dated June 20, 1992, from R. W.Soller, Nonprescription Drug Manufacturers Association, to W. E. Gilbertson, FDA, in OTC Vol. 190036, Docket No. 95N 0062, Dockets Management Branch.",Supporting & Related Material,Background Material,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T15:17:55Z,,0,0,09000064824a4be6
FDA-1995-N-0225-0009,FDA,FDA-1995-N-0225,Answer from FDA CDER to Comment from Nonprescription Drug Manufacturer's Association,Other,Answer,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T14:56:09Z,,0,0,09000064805718b6
FDA-1995-N-0225-0002,FDA,FDA-1995-N-0225,Internal Memorandum from FDA CDER to FDA DDM,Other,Memorandum,2017-02-01T05:00:00Z,2017,2,,,2024-07-30T14:53:21Z,,0,0,09000064824a4beb